Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan

Mariko Harada-Shiba, Hidenori Arai, Tomonori Okamura, Koutaro Yokote, Shinichi Oikawa, Atsushi Nohara, Tomoo Okada, Takao Ohta, Hideaki Bujo, Makoto Watanabe, Akihiko Wakatsuki, Shizuya Yamashita

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Aim: Heterozygous patients of familial hypercholesterolemia (FH) are known to have a high risk of coronary artery disease (CAD). Early diagnosis and prompt treatment are necessary to prevent their CAD. In this study we tried to amend the Japanese diagnostic criteria of FH for general practitioners by examining each component of the current criteria. Methods: A multicenter study was performed, which included 1356 dyslipidemic patients at 6 centers. Pretreatment demographic information including LDL-cholesterol (LDL-C), Achilles tendon thickness (ATT), family history of FH and premature CAD and the result of genetic analysis were analyzed. Results: Of 1356 patients, 419 were diagnosed with FH by criteria in 1988, which were used as a golden standard. We tried to define FH according to 3 conventional major items, i.e., 1) LDL-C, 2) ATT and/or cutaneous nodular xanthomas (CX), 3) family history of FH and/or family history of premature CAD. We then determined the cutoff of LDL-C using the new criteria. When we used 180 mg/dL as the cutoff of LDL-C, 94.3% of FH patients and 0.85% of non-FH satisfied 2 or more criteria. When we used 190 mg/dL, 92.1% of FH and 0.85% of non-FH satisfied 2 or more criteria; therefore, we chose 180 mg/dL for the cutoff of LDL-C in the new criteria and proposed that the diagnosis of definite FH can be made if 2 or more criteria are satisfied. Conclusions: We examined each component for the diagnosis of heterozygous FH in a multicenter study in Japan.

Original languageEnglish
Pages (from-to)1019-1026
Number of pages8
JournalJournal of Atherosclerosis and Thrombosis
Volume19
Issue number11
DOIs
Publication statusPublished - 2012

Fingerprint

Hyperlipoproteinemia Type II
LDL Cholesterol
Multicenter Studies
Japan
Tendons
Coronary Artery Disease
Achilles Tendon
Hypercholesterolemia
Xanthomatosis
LDL Lipoproteins
General Practitioners
Early Diagnosis
Demography
Skin

Keywords

  • Achilles tendon thickness
  • Diagnosis criteria
  • Familial hypercholesterolemia
  • LDL cholesterol
  • LDL receptor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Biochemistry, medical

Cite this

Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. / Harada-Shiba, Mariko; Arai, Hidenori; Okamura, Tomonori; Yokote, Koutaro; Oikawa, Shinichi; Nohara, Atsushi; Okada, Tomoo; Ohta, Takao; Bujo, Hideaki; Watanabe, Makoto; Wakatsuki, Akihiko; Yamashita, Shizuya.

In: Journal of Atherosclerosis and Thrombosis, Vol. 19, No. 11, 2012, p. 1019-1026.

Research output: Contribution to journalArticle

Harada-Shiba, M, Arai, H, Okamura, T, Yokote, K, Oikawa, S, Nohara, A, Okada, T, Ohta, T, Bujo, H, Watanabe, M, Wakatsuki, A & Yamashita, S 2012, 'Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan', Journal of Atherosclerosis and Thrombosis, vol. 19, no. 11, pp. 1019-1026. https://doi.org/10.5551/jat.14159
Harada-Shiba, Mariko ; Arai, Hidenori ; Okamura, Tomonori ; Yokote, Koutaro ; Oikawa, Shinichi ; Nohara, Atsushi ; Okada, Tomoo ; Ohta, Takao ; Bujo, Hideaki ; Watanabe, Makoto ; Wakatsuki, Akihiko ; Yamashita, Shizuya. / Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. In: Journal of Atherosclerosis and Thrombosis. 2012 ; Vol. 19, No. 11. pp. 1019-1026.
@article{c1be17a013c74029a70d0ee445e3e672,
title = "Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan",
abstract = "Aim: Heterozygous patients of familial hypercholesterolemia (FH) are known to have a high risk of coronary artery disease (CAD). Early diagnosis and prompt treatment are necessary to prevent their CAD. In this study we tried to amend the Japanese diagnostic criteria of FH for general practitioners by examining each component of the current criteria. Methods: A multicenter study was performed, which included 1356 dyslipidemic patients at 6 centers. Pretreatment demographic information including LDL-cholesterol (LDL-C), Achilles tendon thickness (ATT), family history of FH and premature CAD and the result of genetic analysis were analyzed. Results: Of 1356 patients, 419 were diagnosed with FH by criteria in 1988, which were used as a golden standard. We tried to define FH according to 3 conventional major items, i.e., 1) LDL-C, 2) ATT and/or cutaneous nodular xanthomas (CX), 3) family history of FH and/or family history of premature CAD. We then determined the cutoff of LDL-C using the new criteria. When we used 180 mg/dL as the cutoff of LDL-C, 94.3{\%} of FH patients and 0.85{\%} of non-FH satisfied 2 or more criteria. When we used 190 mg/dL, 92.1{\%} of FH and 0.85{\%} of non-FH satisfied 2 or more criteria; therefore, we chose 180 mg/dL for the cutoff of LDL-C in the new criteria and proposed that the diagnosis of definite FH can be made if 2 or more criteria are satisfied. Conclusions: We examined each component for the diagnosis of heterozygous FH in a multicenter study in Japan.",
keywords = "Achilles tendon thickness, Diagnosis criteria, Familial hypercholesterolemia, LDL cholesterol, LDL receptor",
author = "Mariko Harada-Shiba and Hidenori Arai and Tomonori Okamura and Koutaro Yokote and Shinichi Oikawa and Atsushi Nohara and Tomoo Okada and Takao Ohta and Hideaki Bujo and Makoto Watanabe and Akihiko Wakatsuki and Shizuya Yamashita",
year = "2012",
doi = "10.5551/jat.14159",
language = "English",
volume = "19",
pages = "1019--1026",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "11",

}

TY - JOUR

T1 - Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan

AU - Harada-Shiba, Mariko

AU - Arai, Hidenori

AU - Okamura, Tomonori

AU - Yokote, Koutaro

AU - Oikawa, Shinichi

AU - Nohara, Atsushi

AU - Okada, Tomoo

AU - Ohta, Takao

AU - Bujo, Hideaki

AU - Watanabe, Makoto

AU - Wakatsuki, Akihiko

AU - Yamashita, Shizuya

PY - 2012

Y1 - 2012

N2 - Aim: Heterozygous patients of familial hypercholesterolemia (FH) are known to have a high risk of coronary artery disease (CAD). Early diagnosis and prompt treatment are necessary to prevent their CAD. In this study we tried to amend the Japanese diagnostic criteria of FH for general practitioners by examining each component of the current criteria. Methods: A multicenter study was performed, which included 1356 dyslipidemic patients at 6 centers. Pretreatment demographic information including LDL-cholesterol (LDL-C), Achilles tendon thickness (ATT), family history of FH and premature CAD and the result of genetic analysis were analyzed. Results: Of 1356 patients, 419 were diagnosed with FH by criteria in 1988, which were used as a golden standard. We tried to define FH according to 3 conventional major items, i.e., 1) LDL-C, 2) ATT and/or cutaneous nodular xanthomas (CX), 3) family history of FH and/or family history of premature CAD. We then determined the cutoff of LDL-C using the new criteria. When we used 180 mg/dL as the cutoff of LDL-C, 94.3% of FH patients and 0.85% of non-FH satisfied 2 or more criteria. When we used 190 mg/dL, 92.1% of FH and 0.85% of non-FH satisfied 2 or more criteria; therefore, we chose 180 mg/dL for the cutoff of LDL-C in the new criteria and proposed that the diagnosis of definite FH can be made if 2 or more criteria are satisfied. Conclusions: We examined each component for the diagnosis of heterozygous FH in a multicenter study in Japan.

AB - Aim: Heterozygous patients of familial hypercholesterolemia (FH) are known to have a high risk of coronary artery disease (CAD). Early diagnosis and prompt treatment are necessary to prevent their CAD. In this study we tried to amend the Japanese diagnostic criteria of FH for general practitioners by examining each component of the current criteria. Methods: A multicenter study was performed, which included 1356 dyslipidemic patients at 6 centers. Pretreatment demographic information including LDL-cholesterol (LDL-C), Achilles tendon thickness (ATT), family history of FH and premature CAD and the result of genetic analysis were analyzed. Results: Of 1356 patients, 419 were diagnosed with FH by criteria in 1988, which were used as a golden standard. We tried to define FH according to 3 conventional major items, i.e., 1) LDL-C, 2) ATT and/or cutaneous nodular xanthomas (CX), 3) family history of FH and/or family history of premature CAD. We then determined the cutoff of LDL-C using the new criteria. When we used 180 mg/dL as the cutoff of LDL-C, 94.3% of FH patients and 0.85% of non-FH satisfied 2 or more criteria. When we used 190 mg/dL, 92.1% of FH and 0.85% of non-FH satisfied 2 or more criteria; therefore, we chose 180 mg/dL for the cutoff of LDL-C in the new criteria and proposed that the diagnosis of definite FH can be made if 2 or more criteria are satisfied. Conclusions: We examined each component for the diagnosis of heterozygous FH in a multicenter study in Japan.

KW - Achilles tendon thickness

KW - Diagnosis criteria

KW - Familial hypercholesterolemia

KW - LDL cholesterol

KW - LDL receptor

UR - http://www.scopus.com/inward/record.url?scp=84870737130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870737130&partnerID=8YFLogxK

U2 - 10.5551/jat.14159

DO - 10.5551/jat.14159

M3 - Article

VL - 19

SP - 1019

EP - 1026

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 11

ER -